Target Information
Altavo GmbH, founded in February 2021, is a medical technology startup based in Dresden. It specializes in developing innovative voice rehabilitation solutions using non-invasive radar sensing and artificial intelligence, aimed at improving the rehabilitation of mute and severely speech-impaired patients. The company employs 15 staff members with extensive experience in fields such as AI, data science, speech technology, high-frequency technology, medical technology, and voice therapy. Altavo collaborates with the Technical University of Dresden, particularly with its departments for Speech Technology and Cognitive Systems and High-Frequency Technology. This partnership is supported by projects funded by the Federal Ministry of Education and Research and the Saxon Development Bank.
Industry Overview
Germany has a robust medical technology sector, recognized globally for its innovative approaches and high-quality standards. The country is home to several leading companies in the medical device industry, particularly in fields like rehabilitation technology, which has seen considerable growth in recent years. An increasing number of aging populations and patients with chronic conditions drive demand for effective rehabilitation solutions.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The German health care system infrastructure plays an essential role in facilitating the adoption of new medical technologies. With a strong emphasis on research and development, Ger
Similar Deals
Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, Wellington Partners, Bayern Kapital, High-Tech Gründerfonds, PhiFund Ventures → SciRhom GmbH
2024
OCCIDENT
invested in
Altavo GmbH
in 2024
in a Series A deal
Disclosed details
Transaction Size: $5M